PH31291A - Process for the preparation of chlorosulfate and sulfate derivatives of 2,3,4,5-bis-o-(1-methylidene)-b-d-fructopyranose and 91-cyclohexyl methanol. - Google Patents

Process for the preparation of chlorosulfate and sulfate derivatives of 2,3,4,5-bis-o-(1-methylidene)-b-d-fructopyranose and 91-cyclohexyl methanol.

Info

Publication number
PH31291A
PH31291A PH44955A PH44955A PH31291A PH 31291 A PH31291 A PH 31291A PH 44955 A PH44955 A PH 44955A PH 44955 A PH44955 A PH 44955A PH 31291 A PH31291 A PH 31291A
Authority
PH
Philippines
Prior art keywords
chlorosulfate
fructopyranose
bis
methylidene
preparation
Prior art date
Application number
PH44955A
Other languages
English (en)
Inventor
Cynthia A Maryanoff
Scott Lorraine
Kirk L Sorgi
Original Assignee
Mcunilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcunilab Inc filed Critical Mcunilab Inc
Publication of PH31291A publication Critical patent/PH31291A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/34—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfuric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH44955A 1991-09-19 1992-09-18 Process for the preparation of chlorosulfate and sulfate derivatives of 2,3,4,5-bis-o-(1-methylidene)-b-d-fructopyranose and 91-cyclohexyl methanol. PH31291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76272091A 1991-09-19 1991-09-19
US92626992A 1992-08-05 1992-08-05

Publications (1)

Publication Number Publication Date
PH31291A true PH31291A (en) 1998-07-06

Family

ID=27117178

Family Applications (1)

Application Number Title Priority Date Filing Date
PH44955A PH31291A (en) 1991-09-19 1992-09-18 Process for the preparation of chlorosulfate and sulfate derivatives of 2,3,4,5-bis-o-(1-methylidene)-b-d-fructopyranose and 91-cyclohexyl methanol.

Country Status (23)

Country Link
US (1) US5387700A (de)
EP (1) EP0533483B1 (de)
JP (1) JP3174410B2 (de)
KR (1) KR100229180B1 (de)
CN (1) CN1035820C (de)
AT (1) ATE163937T1 (de)
AU (1) AU651244B2 (de)
CA (1) CA2078519C (de)
DE (1) DE69224691T2 (de)
DK (1) DK0533483T3 (de)
EG (1) EG20164A (de)
ES (1) ES2114917T3 (de)
FI (1) FI107731B (de)
GR (1) GR3026618T3 (de)
HU (1) HU212634B (de)
IL (1) IL103172A (de)
MX (1) MX9205305A (de)
MY (1) MY113564A (de)
NO (1) NO179284C (de)
NZ (1) NZ244409A (de)
PH (1) PH31291A (de)
TW (1) TW217413B (de)
ZW (1) ZW14792A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3250777B2 (ja) * 1995-02-13 2002-01-28 セントラル硝子株式会社 イミド類、その塩類およびそれらの製造法
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
JP2002539088A (ja) * 1999-02-17 2002-11-19 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 本態性振せんを処置するのに有用な抗痙攣性誘導体
US6420369B1 (en) 1999-05-24 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating dementia
CA2415093A1 (en) * 2000-07-07 2002-01-17 Carlos Plata-Salaman Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
EP1309325A1 (de) 2000-08-02 2003-05-14 Ortho-McNeil Pharmaceutical, Inc. Antikonvulsive derivate zur behandlung von depression
PT1333887E (pt) 2000-10-30 2006-10-31 Ortho Mcneil Pharm Inc Metodo de tratamento de desordens musculares
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
WO2003039563A1 (en) * 2001-11-06 2003-05-15 Ortho-Mcneil Pharmaceutical Inc. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
RU2004126093A (ru) * 2002-02-26 2005-04-10 Орто-Макнейл Фармасьютикал, Инк. (Us) Комбинированная терапия для лечения мигрени, включающая применение производных противосудорожных средств и средств от мигрени
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
CA2494233A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
CN100430408C (zh) * 2002-10-31 2008-11-05 奥索-麦克尼尔药品公司 制备吡喃果糖氨基磺酸酯衍生物的连续法
US7196209B2 (en) * 2002-10-31 2007-03-27 Ortho-Mcneil Pharmaceutical, Inc. Continuous process for the preparation of fructopyranose sulfamate derivatives
UA81657C2 (ru) * 2003-03-04 2008-01-25 Орто-Макнейл Фармасьютикел, Инк. Способ получения противосудорожных производных топирамата
WO2004108732A1 (en) * 2003-05-12 2004-12-16 Sun Pharmaceutical Industries Limited PROCESS FOR THE PREPARATION OF 2,3:4,5-BIS-O(1-METHYLETHYLIDENE)-ß-D-FRUCTOPYRANOSE SULFAMATE
US20050058707A1 (en) * 2003-08-06 2005-03-17 Iran Reyes Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
MXPA06002067A (es) * 2003-08-22 2006-08-11 Johnson & Johnson Suministro gradual de topiramato durante periodo prolongado.
WO2005020959A2 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
AU2004291081A1 (en) * 2003-11-14 2005-06-02 Alza Corporation Controlled release of topirimate in liquid dosage forms
KR20050062976A (ko) * 2003-12-19 2005-06-28 일동제약주식회사 2,3:4,5-비스-오-(1-메틸에틸리덴)-베타-디-프럭토피라노즈설파메이트의 새로운 개량된 제조방법
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
EP1701706A2 (de) * 2003-12-29 2006-09-20 Alza Corporation Neue arzneimittelzusammensetzungen und dosierformen
MXPA06007510A (es) * 2003-12-29 2009-06-10 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas de topiramato.
US20050203287A1 (en) * 2004-03-11 2005-09-15 Chandrasekhar Batchu Process for the preparation of sulfamate derivatives
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DE602005008084D1 (de) * 2004-08-24 2008-08-21 Janssen Pharmaceutica Nv Als antikonvulsive mittel geeignete neue benzokondensierte heteroarylsulfamidderivate
MX364884B (es) * 2004-10-05 2019-05-10 Fallbrook Intellectual Property Company Llc Star Transmisión continuamente variable.
KR20080012360A (ko) * 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
EP1888030A1 (de) * 2005-05-25 2008-02-20 Janssen Pharmaceutica N.V. Pädiatrische formulierung von topiramat
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US20070191461A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
US20070191449A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
US20070191459A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
US20070191453A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
WO2007099388A1 (en) * 2006-03-01 2007-09-07 Glade Organics Private Limited An improved process for the manufacture of topiramate
WO2007108009A1 (en) * 2006-03-17 2007-09-27 Alembic Limited A process for purification of topiramate
EA200870556A1 (ru) * 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
JP5424571B2 (ja) * 2007-04-12 2014-02-26 協和発酵キリン株式会社 トピラマート含有固形製剤
EP2142826B1 (de) * 2007-04-24 2015-10-28 Fallbrook Intellectual Property Company LLC Elektrische zugvorrichtungen
CN101450951B (zh) * 2007-11-30 2012-10-10 重庆凯林制药有限公司 托吡酯的制备方法
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
EA018567B1 (ru) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8748594B2 (en) 2010-02-05 2014-06-10 Scinopharm Taiwan, Ltd. Process for the preparation and purification of topiramate
CN102936268A (zh) * 2012-11-13 2013-02-20 江苏吉贝尔药业有限公司 一种托吡酯中间体丙酮叉的制备方法
CN106397502A (zh) * 2016-08-31 2017-02-15 安徽省润生医药股份有限公司 一种托吡酯的合成工艺
CN108341844A (zh) * 2018-04-25 2018-07-31 广州小桔生物科技有限公司 一种高纯度托吡酯的制备方法
CN110655541A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯晶型
CN110655542A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯的晶型
EP3883546A1 (de) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Orale topiramat-suspensionsformulierungen mit verlängerter lagerstabilität und verbesserter bioverfügbarkeit
CN114350340B (zh) * 2022-01-13 2023-01-17 陕西科技大学 一种压裂用增渗剂及其制备方法和应用
WO2025049333A2 (en) * 2023-08-25 2025-03-06 University Of Iowa Research Foundation Therapeutic compounds and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4582916A (en) * 1983-09-26 1986-04-15 Mcneilab, Inc. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol

Also Published As

Publication number Publication date
AU651244B2 (en) 1994-07-14
HU212634B (en) 1996-09-30
NO923637L (no) 1993-03-22
EP0533483A3 (en) 1994-11-02
MY113564A (en) 2002-04-30
FI924189L (fi) 1993-03-20
GR3026618T3 (en) 1998-07-31
NO179284C (no) 1996-09-11
TW217413B (de) 1993-12-11
FI107731B (fi) 2001-09-28
JPH05230011A (ja) 1993-09-07
CN1075317A (zh) 1993-08-18
EP0533483A2 (de) 1993-03-24
CN1035820C (zh) 1997-09-10
NZ244409A (en) 1995-02-24
AU2451892A (en) 1993-03-25
ES2114917T3 (es) 1998-06-16
IL103172A0 (en) 1993-02-21
KR100229180B1 (ko) 1999-11-01
CA2078519A1 (en) 1993-03-20
KR930006029A (ko) 1993-04-20
DE69224691T2 (de) 1998-08-20
FI924189A0 (fi) 1992-09-18
ATE163937T1 (de) 1998-03-15
EP0533483B1 (de) 1998-03-11
US5387700A (en) 1995-02-07
MX9205305A (es) 1993-07-01
HUT63612A (en) 1993-09-28
EG20164A (en) 1997-08-31
ZW14792A1 (en) 1994-04-20
HU9202974D0 (en) 1992-11-30
DE69224691D1 (de) 1998-04-16
IL103172A (en) 1997-01-10
DK0533483T3 (da) 1998-09-28
JP3174410B2 (ja) 2001-06-11
NO179284B (no) 1996-06-03
CA2078519C (en) 2003-09-16
NO923637D0 (no) 1992-09-18

Similar Documents

Publication Publication Date Title
PH31291A (en) Process for the preparation of chlorosulfate and sulfate derivatives of 2,3,4,5-bis-o-(1-methylidene)-b-d-fructopyranose and 91-cyclohexyl methanol.
MX9101524A (es) Proceso para la sintesis de un copolimero de isopreno-butadieno con alto contenido de vinilo
AU630783B2 (en) A method of operating an installation for the production of biaxially stretched plastic tubes
WO1999019127A3 (en) Wall forming system and method of forming a wall of hardenable material
GB2283257B (en) Thermoplastic structural system and components therefor and method of making same
EP0616906A3 (de) Verfahren zur Herstellung einer dekoratieven Folie.
BR9607149A (pt) Produção e recuperação de éter dimetílico a partir de metanol
FI906006A7 (fi) Menetelmä vaahtomuovien valmistamiseksi
EP0616994A3 (de) Verfahren zur Herstellung von Etheralkoholen durch Hydrogenolyse von zyklischem Ketal.
EP0609983A3 (de) Zusammensetzung auf Basis von Stärke.
FR2661872B1 (fr) Procede de fabrication d'un pare-soleil recouvert de tissu.
CA2213131A1 (en) Low base number sulphonates
EP0476528A3 (en) Process for producing stable latex
EP0679039A3 (de) Verfahren zur Produktion eines Fernsehempfängers.
DE69002765D1 (de) Verfahren zur herstellung eines deckenpaneels.
ES2087129T3 (es) Sintesis enantioselectiva de antifoliatos.
HU904906D0 (en) Process for producing alpha-1-aspartil-1-phenylalanine-methyl-esther-hydrochloride utilizing separated n-formyl-1-aspartil-anhydride
EP0261872A3 (de) Biosyntheseverfahren
IT7829321A0 (it) Processo pert la preparazione di un copolimero di esteri vinilici.
HUT62266A (en) Process for producing 1-/3-mercapto/25/-methyl-1-oxopropyl/-l-proline
EP0637776A4 (de) Photoempfindliche Harzzusammensetzung und Verfahen zur Herstellung einesReliefmusters mit dieser Zusammensetzung.
EP0550626A4 (en) Method of improving the yield of heterologous proteins produced by streptomyces lividans
ES461175A1 (es) Un procedimiento de preparar nuevas 2,3-alcohilen-bis-(oxi)-benzamidas sustituidas.
HUT60324A (en) Process for producing compositions of yeast biomass base
KR970046523U (ko) 패널의 스크린 공정중 위치 전환 불량 패널 배출장치